Trial intelligence / Profile preview

Azithromycin and Intensified Insulin in Type 1 Diabetes

NCT03682640Phase 2Unknown

Sponsor
Uppsala University
Start
Sep 2018
Primary completion
Dec 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of azithromycin in type 1 diabetes mellitus (T1D), sponsored by Uppsala University. Status: unknown.

02

Drugs

azithromycin
03

Conditions

type 1 diabetes mellitus (T1D)

Beyond the preview

Go deeper on NCT03682640.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03682640.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call